These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 8781313

  • 41. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically.
    Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ.
    J Med Virol; 2005 Jun; 76(2):194-202. PubMed ID: 15834881
    [Abstract] [Full Text] [Related]

  • 42. Hepatitis B virus genotypes and precore mutations in Scottish blood donors.
    Davidson F, Lycett C, Sablon E, Petrik J, Dow BC.
    Vox Sang; 2005 Feb; 88(2):87-92. PubMed ID: 15720605
    [Abstract] [Full Text] [Related]

  • 43. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance.
    Lok AS, Akarca US, Greene S.
    Hepatology; 1995 Jan; 21(1):19-24. PubMed ID: 7528709
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Analysis of carriers of hepatitis B virus from a tertiary referral hospital: does the viral load change during the natural course of infection?
    Aakanksha, Asim M, Sharma PK, Das BC, Kar P.
    J Med Virol; 2011 Jul; 83(7):1151-8. PubMed ID: 21520137
    [Abstract] [Full Text] [Related]

  • 46. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [Abstract] [Full Text] [Related]

  • 47. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R, Marrone A, Karayiannis P, Cirillo G, del Giudice EM, Rania G, Utili R, Ruggiero G.
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [Abstract] [Full Text] [Related]

  • 48. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [Abstract] [Full Text] [Related]

  • 49. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis.
    Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosoda K, Ohto M.
    J Clin Invest; 1993 Mar; 91(3):1206-13. PubMed ID: 8450049
    [Abstract] [Full Text] [Related]

  • 53. [Detection and characterization of pre-core mutants of hepatitis B virus (HBV) in chronically infected patients].
    López JL, Telenta PF, Palacios Poggio González J, Alonso AG, Lemberg A, Campos R.
    Acta Gastroenterol Latinoam; 1995 Mar; 25(2):85-90. PubMed ID: 8525764
    [Abstract] [Full Text] [Related]

  • 54. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
    Chan HL, Leung NW, Hussain M, Wong ML, Lok AS.
    Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
    [Abstract] [Full Text] [Related]

  • 55. Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus.
    Stuyver L, De Gendt S, Cadranel JF, Van Geyt C, Van Reybroeck G, Dorent R, Gandjbachkh I, Rosenheim M, Charlotte F, Opolon P, Huraux JM, Lunel F.
    Hepatology; 1999 Jun; 29(6):1876-83. PubMed ID: 10347133
    [Abstract] [Full Text] [Related]

  • 56. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
    Shin JW, Chung YH, Choi MH, Kim JA, Ryu SH, Jang MK, Kim IS, Park NH, Lee HC, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):844-9. PubMed ID: 15946130
    [Abstract] [Full Text] [Related]

  • 57. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 58. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K, Imazeki F, Fukai K, Arai M, Kanda T, Mikata R, Yokosuka O.
    J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children.
    Barbera C, Calvo P, Coscia A, Perugini L, Dastoli G, Randone A, Bonino F, Brunetto MR.
    Pediatr Res; 1994 Sep; 36(3):347-50. PubMed ID: 7528908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.